Triamcinolone hexacetonide
Clinical data | |
---|---|
Trade names | Aristospan |
Other names | Triamcinolone acetonide 21-tebutate; Triamcinolone acetonide 21-(tert-butylacetate); 9α-Fluoro-11β,16α,17α,21-tetrahydroxypregna-1,4-diene-3,20-dione cyclic 16,17-acetal with acetone, 21-(3,3-dimethylbutyrate); 9α-Fluoro-11β-hydroxy-16α,17α-((1-methylethylidene)bis(oxy))pregna-1,4-diene-3,20-dione 21-(3,3-dimethylbutyrate) |
Drug class | Corticosteroid; Glucocorticoid |
Legal status | |
Legal status | |
Identifiers | |
| |
JSmol) | |
| |
|
Triamcinolone hexacetonide (brand name Aristospan; also known as triamcinolone acetonide 21-tebutate) is a
It is on the World Health Organization's List of Essential Medicines.[6]
References
- ^ "Arthritis". Health Canada. 8 May 2018. Retrieved 13 April 2024.
- ^ "Regulatory Decision Summary for Triamcinolone Hexacetonide Injectable Suspension". Drug and Health Products Portal. 12 December 2017. Retrieved 13 April 2024.
- ISBN 978-1-4757-2085-3.
- ISBN 978-3-88763-075-1.
- ISBN 978-94-011-4439-1.
- hdl:10665/371090. WHO/MHP/HPS/EML/2023.02.